IFP Advisors’s NanoViricides NNVC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-1,000
Closed -$1.17K 4983
2025
Q1
$1.17K Hold
1,000
﹤0.01% 3299
2024
Q4
$1.43K Hold
1,000
﹤0.01% 3201
2024
Q3
$1.5K Hold
1,000
﹤0.01% 2993
2024
Q2
$1.72K Hold
1,000
﹤0.01% 2843
2024
Q1
$1.16K Buy
+1,000
New +$1.15K ﹤0.01% 2831
2022
Q4
Sell
-21
Closed -$1K 4756
2022
Q3
$1K Hold
21
﹤0.01% 4621
2022
Q2
$1K Hold
21
﹤0.01% 4398
2022
Q1
$1K Sell
21
-7
-25% -$16 ﹤0.01% 4397
2021
Q4
$1K Sell
28
-3
-10% -$14 ﹤0.01% 3062
2021
Q3
$1K Sell
31
-3,639
-99% -$15.2K ﹤0.01% 3077
2021
Q2
$18K Buy
3,670
+10
+0.3% +$40 ﹤0.01% 1983
2021
Q1
$19K Buy
3,660
+298
+9% +$1.35K ﹤0.01% 1877
2020
Q4
$10K Buy
3,362
+1,991
+145% +$7.25K ﹤0.01% 2080
2020
Q3
$5K Buy
+1,371
New +$7.52K ﹤0.01% 2181
2018
Q4
Sell
-92
Closed -$1K 3753
2018
Q3
$1K Hold
92
﹤0.01% 3704
2018
Q2
$1K Hold
92
﹤0.01% 3748
2018
Q1
$2K Hold
92
﹤0.01% 3520
2017
Q4
$2K Hold
92
﹤0.01% 3571
2017
Q3
$2K Hold
92
﹤0.01% 3766
2017
Q2
$2K Sell
92
-5
-5% -$124 ﹤0.01% 3746
2017
Q1
$2K Buy
97
+92
+1,840% +$2.15K ﹤0.01% 3669
2016
Q4
$0 Hold
5
﹤0.01% 4081
2016
Q3
$0 Hold
5
﹤0.01% 3987
2016
Q2
$0 Buy
+5
New +$182 ﹤0.01% 3991
2016
Q1
Sell
-5
Closed 3048
2015
Q4
$0 Buy
+5
New +$120 ﹤0.01% 3769

Other funds holding NNVC

IFP Advisors's NNVC Position: Q2 2025 in Review

IFP Advisors sold out of NanoViricides (NNVC) in Q2 2025, closing a stake of 1,000 shares — an estimated $1.17K sold.

IFP Advisors first reported a position in NNVC in Q4 2015 and held it in 25 quarters. The position peaked at $19K in Q1 2021. 33 funds tracked by Wall St. Rank hold NNVC as of Q2 2025.

  • IFP Advisors reported no remaining NanoViricides position as of Q2 2025 after selling out during the quarter.
  • IFP Advisors sold 1,000 NanoViricides shares in Q2 2025, an estimated $1.17K.
  • IFP Advisors first reported a position in NanoViricides in Q4 2015 and held it in 25 quarters.
  • IFP Advisors's NanoViricides position peaked at $19K in Q1 2021.
  • 33 funds tracked by Wall St. Rank held NanoViricides as of Q2 2025.

Based on IFP Advisors's 13F filing for Q2 2025, filed 24 Jul 2025.